Research Topics
Species | C Gregory ElliottSummaryAffiliation: LDS Hospital Country: USA Publications
| Collaborators
|
Detail Information
Publications
Validation of a brief telephone battery for neurocognitive assessment of patients with pulmonary arterial hypertensionDarren B Taichman
Pulmonary, Allergy and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
Respir Res 6:39. 2005..We undertook this study to validate telephone administration of the tests...
Delays in diagnosis of deep vein thrombosis and pulmonary embolismC Gregory Elliott
Department of Medicine, Pulmonary Division, LDS Hospital, University of Utah, Salt Lake City, 84143, USA
Chest 128:3372-6. 2005..To investigate delays in the diagnosis of deep vein thrombosis (DVT) and pulmonary embolism (PE)...- Genetics of pulmonary arterial hypertension: current and future implicationsC Gregory Elliott
Pulmonary Division, Latter Day Saints Hospital, Salt Lake City, UT 84143, USA
Semin Respir Crit Care Med 26:365-71. 2005..These discoveries coupled with other basic investigations offer opportunities for advances in the management of pulmonary arterial hypertension... - Hyperbaric oxygen for acute carbon monoxide poisoningLindell K Weaver
Department of Internal Medicine, Pulmonary and Critical Care Division, LDS Hospital, Salt Lake City, Utah 84143, USA
N Engl J Med 347:1057-67. 2002..Patients with acute carbon monoxide poisoning commonly have cognitive sequelae. We conducted a double-blind, randomized trial to evaluate the effect of hyperbaric-oxygen treatment on such cognitive sequelae... 
Risk of symptomatic DVT associated with peripherally inserted central cathetersR Scott Evans
Medical Informatics, Intermountain Healthcare, Salt Lake City, UT, USA
Chest 138:803-10. 2010..PICC insertion teams and other health-care providers need to understand the risk factors so that they can develop methods to prevent DVT...- Genetics and pharmacogenomics in pulmonary arterial hypertensionBenjamin P Smith
Division of Pulmonary and Critical Care Medicine, University of Utah, Maxwell Wintrobe Research Building, 26 North Medical Drive, Salt Lake City, UT 84132, USA
Heart Fail Clin 8:319-30. 2012..Warfarin is often used as an adjuvant therapy in patients with PAH... - Radiation and chest CT scan examinations: what do we know?Asha Sarma
Department of Medicine, Intermountain Medical Center, Murray, UT, USA
Chest 142:750-60. 2012..CT scan examinations of the chest, including CT scan pulmonary and coronary angiography, high-resolution CT scan, low-dose lung cancer screening, and triple rule-out CT scan, are specifically considered... - Sustained improvement with iloprost in a COPD patient with severe pulmonary hypertensionMatthew J Hegewald
Division of Pulmonary and Critical Care Medicine Intermountain Medical Center, University of Utah School of Medicine, Salt Lake City, UT 84157 7000, USA
Chest 135:536-7. 2009..The improvement was sustained for 2 years. Severe PH in patients with COPD needs to be recognized and novel treatment approaches considered... - Physician alerts to prevent symptomatic venous thromboembolism in hospitalized patientsGregory Piazza
Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Circulation 119:2196-201. 2009.... - Relationship of BMPR2 mutations to vasoreactivity in pulmonary arterial hypertensionC Gregory Elliott
LDS Hospital, University of Utah School of Medicine, Salt Lake City, Utah, USA
Circulation 113:2509-15. 2006..Previous investigations have not examined the relationship of BMPR2 mutations to vasoreactivity... - Diagnosis: imaging techniquesC Gregory Elliott
Department of Medicine, Intermountain Medical Center, 5121 South Cottonwood Street, Suite 307, Murray, UT 84107, USA
Clin Chest Med 31:641-57. 2010..Bedside echocardiography may be most appropriate for patients with hypotension or shock and suspected pulmonary embolism... - Worldwide physician education and training in pulmonary hypertension: pulmonary vascular disease: the global perspectiveC Gregory Elliott
Department of Medicine, Division of Pulmonary and Critical Care Medicine, Intermountain Medical Center, Murray, UT 84157 7000, USA
Chest 137:85S-94S. 2010..Political, economic, and cultural barriers must be identified and overcome as part of any strategic plan. Global education should include training objectives for generalist, non-PH specialist, and PH specialist physicians... - Pulmonary disease is a component of distal arthrogryposis type 5Marc S Williams
Clinical Genetics Institute Intermountain Health Care, Salt Lake City, UT 84103, USA
Am J Med Genet A 143:752-6. 2007..All individuals diagnosed with DA5 should be evaluated for chest disease, alveolar hypoventilation, as treatment of chronic hypoxia may delay or reverse pulmonary hypertension... - Acute pulmonary embolism: part I: epidemiology, pathophysiology, and diagnosisSamuel Z Goldhaber
Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, 75 Francis St, Boston, Mass 02115, USA
Circulation 108:2726-9. 2003 - Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL RegistryLynette M Brown
Department of Medicine, Division of Pulmonary and Critical Care Medicine, Intermountain Medical Center, Murray, UT 84157 7000, USA
Chest 140:19-26. 2011..Despite the emergence of effective therapy, PAH is commonly at an advanced stage when recognized. Factors associated with a prolonged symptomatic period before the recognition of PAH have not been fully evaluated... - Withholding anticoagulation after a negative result on duplex ultrasonography for suspected symptomatic deep venous thrombosisScott M Stevens
LDS Hospital and University of Utah, Salt Lake City, Utah 84143, USA
Ann Intern Med 140:985-91. 2004..Repeated testing is costly and inconvenient, and patients are sometimes less likely to return for follow-up tests... - Carbon Monoxide Research Group, LDS Hospital, Utah in reply to Scheinkestel et al. and Emerson: the role of hyperbaric oxygen in carbon monoxide poisoningLindell K Weaver
Department of Medicine, Pulmonary Critical Care Divisions, LDS Hospital, Salt Lake City, Utah, USA
Emerg Med Australas 16:394-9; discussion 481-2. 2004..and the accompanying Commentary: 'The dilemma of managing carbon monoxide poisoning' by Emerson published in the April issue of Emergency Medicine Australasia... - Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolismPaul M Ridker
Center for Cardiovascular Disease Prevention and the Division of Preventive Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston 02215, USA
N Engl J Med 348:1425-34. 2003..0 and 3.0. However, for long-term management, no therapeutic agent has shown an acceptable benefit-to-risk ratio... - Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertensionRajiv D Machado
Division of Medical Genetics, Department of Genetics, University of Leicester, Leicester, United Kingdom
Hum Mutat 27:121-32. 2006.... - Cognitive, emotional, and quality of life outcomes in patients with pulmonary arterial hypertensionJoanne White
Psychology Department, Brigham Young University, Provo, Utah, USA
Respir Res 7:55. 2006..Our secondary purpose was to determine the relationships between cognitive sequelae and neuropsychological test scores with depression, anxiety, and quality of life... - Acute pulmonary embolism: part II: risk stratification, treatment, and preventionSamuel Z Goldhaber
Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass 02115, USA
Circulation 108:2834-8. 2003 - Genetic association of the serotonin transporter in pulmonary arterial hypertensionRajiv D Machado
Division of Medical Genetics, Department of Genetics, University of Leicester, Leicester, UK
Am J Respir Crit Care Med 173:793-7. 2006.... - Mars or venus--is sex a risk factor for recurrent venous thromboembolism?C Gregory Elliott
N Engl J Med 350:2614-6. 2004 - The effect of a computerized reminder system on the prevention of postoperative venous thromboembolismDavid Mosen
Department of Public Health and Preventive Medicine, Oregon Health and Science University, Portland, OR, USA
Chest 125:1635-41. 2004..New strategies are needed to address prophylaxis-resistant venous thromboembolism... - Dose proportionality of treprostinil sodium administered by continuous subcutaneous and intravenous infusionC Shane McSwain
Clinical Affairs, United Therapeutics Corporation, One Park Drive, 4th Floor, Research Triangle Park, NC 27709, USA
J Clin Pharmacol 48:19-25. 2008..941 (95% confidence interval: 0.809-1.073). This study supports previous findings of linearity at lower doses up to 15 ng/kg/min and demonstrates linearity at treprostinil doses up to 125 ng/kg/min...